BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Diagnosis
610 results:

  • 1. Contemporary Diagnostic Reporting for Prostatic Adenocarcinoma: Morphologic Aspects, Molecular Correlates, and Management Perspectives.
    Muthusamy S; Smith SC
    Adv Anat Pathol; 2024 May; 31(3):188-201. PubMed ID: 38525660
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biomarker Inference and the Timing of Next-Generation Sequencing in a Multi-Institutional, Cross-cancer Clinicogenomic Data set.
    Kehl KL; Lavery JA; Brown S; Fuchs H; Riely G; Schrag D; Newcomb A; Nichols C; Micheel CM; Bedard PL; Sweeney SM; Fiandalo M; Panageas KS;
    JCO Precis Oncol; 2024 Mar; 8():e2300489. PubMed ID: 38484212
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development of a prognostic model for long-term survival of young patients with bladder cancer: a retrospective analysis of the SEER Database.
    Guo L; Liu L; Liu Y; Yang T; Wang G; Liu J; Li S; Cai J
    BMJ Open; 2024 Mar; 14(3):e080092. PubMed ID: 38458812
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Highly accurate and effective deep neural networks in pathological diagnosis of prostate cancer.
    Zhang C; Gao X; Fan B; Guo S; Lyu X; Shi J; Fu Y; Zhang Q; Liu P; Guo H
    World J Urol; 2024 Feb; 42(1):93. PubMed ID: 38386116
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Advances in radiology and pathology of prostate cancer: a review for the pathologist.
    Pepe P; Fandella A; Barbera M; Martino P; Merolla F; Caputo A; Fraggetta F
    Pathologica; 2024 Feb; 116(1):1-12. PubMed ID: 38349336
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pan-cancer characterization of cell-free immune-related miRNA identified as a robust biomarker for cancer diagnosis.
    Wu P; Zhang C; Tang X; Li D; Zhang G; Zi X; Liu J; Yin E; Zhao J; Wang P; Wang L; Li R; Wu Y; Sun N; He J
    Mol Cancer; 2024 Feb; 23(1):31. PubMed ID: 38347558
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Impact of prostate-Specific Antigen Screening on prostate cancer Incidence and Mortality in China: 13-Year Prospective Population-Based Cohort Study.
    Ruan X; Zhang N; Wang D; Huang J; Huang J; Huang D; Chun TTS; Ho BSH; Ng AT; Tsu JH; Zhan Y; Na R
    JMIR Public Health Surveill; 2024 Jan; 10():e47161. PubMed ID: 38236627
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of the COVID-19 pandemic on mental health and quality of life in people living with and beyond breast, prostate and colorectal cancer - a qualitative study.
    Pini S; Buck C; Lally P; Beeken R; Fisher A
    BMC Psychol; 2024 Jan; 12(1):25. PubMed ID: 38229188
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Treatment-related Neuroendocrine prostate Carcinoma-Diagnostic and Molecular Correlates.
    Gopalan A
    Adv Anat Pathol; 2024 Mar; 31(2):70-79. PubMed ID: 38223983
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Stimulated Raman Histology Interpretation by Artificial Intelligence Provides Near-Real-Time Pathologic Feedback for Unprocessed prostate Biopsies.
    Mannas MP; Deng FM; Ion-Margineanu A; Jones D; Hoskoppal D; Melamed J; Pastore S; Freudiger C; Orringer DA; Taneja SS
    J Urol; 2024 Mar; 211(3):384-391. PubMed ID: 38100831
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Correlation between membrane proteins and sizes of extracellular vesicles and particles: A potential signature for cancer diagnosis.
    Zhai C; Xie F; Xu J; Yang Y; Zheng W; Hu H; Ding X; Yu H
    J Extracell Vesicles; 2023 Dec; 12(12):e12391. PubMed ID: 38050829
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biosensors Based on Stanniocalcin-1 Protein Antibodies Thin Films for prostate cancer diagnosis.
    Ferreira R; Ribeiro PA; Canário AVM; Raposo M
    Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998156
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score.
    Chen Z; Zhang J; Jin D; Wei X; Qiu F; Wang X; Zhao X; Pu J; Hou J; Huang Y; Huang C
    BMC Cancer; 2023 Nov; 23(1):1138. PubMed ID: 37996859
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer.
    Kovacs B; Netzer N; Baumgartner M; Schrader A; Isensee F; Weißer C; Wolf I; Görtz M; Jaeger PF; Schütz V; Floca R; Gnirs R; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D; Maier-Hein KH
    Sci Rep; 2023 Nov; 13(1):19805. PubMed ID: 37957250
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer.
    Zhu W; Zeng H; Huang J; Wu J; Wang Y; Wang Z; Wang H; Luo Y; Lai W
    J Transl Med; 2023 Nov; 21(1):782. PubMed ID: 37925432
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. New Molecular Markers for prostate cancer diagnosis.
    Amiri M; Asadi Samani L; Kashi AH; Khadem N; Ziaee SAM; Mowla SJ
    Urol J; 2024 Feb; 21(1):1-13. PubMed ID: 37818554
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Development and evaluation of the MiCheck® prostate test for clinically significant prostate cancer.
    Shore ND; Polikarpov DM; Pieczonka CM; Henderson RJ; Bailen JL; Saltzstein DR; Concepcion RS; Beebe-Dimmer JL; Ruterbusch JJ; Levin RA; Wissmueller S; Le TH; Gillatt DA; Chan DW; Deng N; Siddireddy JS; Lu Y; Campbell DH; Walsh BJ
    Urol Oncol; 2023 Nov; 41(11):454.e9-454.e16. PubMed ID: 37734979
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Impact of Prior cancer on the Prognosis of Patients with Chondrosarcoma: A Population-Based Study of the SEER Database.
    Qian J; Dai S; Wang H
    Altern Ther Health Med; 2023 Nov; 29(8):674-679. PubMed ID: 37678875
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Estimating cancer incidence in Uganda: a feasibility study for periodic cancer surveillance research in resource limited settings.
    Nakaganda A; Spencer A; Orem J; Mpamani C; Wabinga H; Nambooze S; Kiwanuka GN; Atwine R; Gemmell I; Jones A; Verma A
    BMC Cancer; 2023 Aug; 23(1):772. PubMed ID: 37596529
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Development and validation a model for predicting overall survival of bladder cancer with lung metastasis: a population-based study.
    Liu L; Sun FZ; Zhang PY; Xiao Y; Ni HX
    Eur J Med Res; 2023 Aug; 28(1):279. PubMed ID: 37559152
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 31.